中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
34期
15-16
,共2页
创新性复方调血脂药物%临床前评价%药理毒理
創新性複方調血脂藥物%臨床前評價%藥理毒理
창신성복방조혈지약물%림상전평개%약리독리
Innovative compound lipid regulating agents%Pre clinical evaluation%Pharmacology and Toxicology
非临床研究不同类型复方制剂研发的方法存在差异。本文首先对组方中单药特点进行分析，根据复方调血脂药物研发准确立题，对目标适应证以及受试人群进行准确分析，针对创新性复方调血脂药物药理毒理进行相关性研究。
非臨床研究不同類型複方製劑研髮的方法存在差異。本文首先對組方中單藥特點進行分析，根據複方調血脂藥物研髮準確立題，對目標適應證以及受試人群進行準確分析，針對創新性複方調血脂藥物藥理毒理進行相關性研究。
비림상연구불동류형복방제제연발적방법존재차이。본문수선대조방중단약특점진행분석，근거복방조혈지약물연발준학립제，대목표괄응증이급수시인군진행준학분석，침대창신성복방조혈지약물약리독리진행상관성연구。
In the non clinical research,methods of different types of compound preparation development is different.In this paper, we first analyze the characteristics of single drug in the prescription,according to compound lipid-lowering drug development accurate legislation,accurately analyze the target indication and human subjects,carry out related research on innovative compound lipid-lowering drug pharmacology and toxicology.
